US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
US approves generic HIV-prevention drug lenacapavir for poorer nations
BU
Business Standard - LatestBy Press Trust of India
EXECUTIVE SUMMARY
US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
Key Takeaways
- US approves generic HIV-prevention drug lenacapavir for poorer nations.
- US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
- US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
Read Complete Original Article
Published originally on Business Standard - Latest
